Determination of ubiquinone Q10 (coenzyme Q10) and its synthesis relatedimpurities by high performance liquid chromatography (HPLC) and massspectrometry (MS)

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1467-1477

  Mahendra, K ^a   Murthy, Y L N ^b   Narasimha Rao, C V ^c   Bala Murali Krishna, K ^d  

^a Research and Development Division   (India)

^b ANDHRA UNIVERSITY   (India)

^c ICAR Central Tobacco Research Institute   (India)

^d ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

APCI MS; Coenzyme Q10; Dietary supplement; Related substances; Reversed phase HPLC

Indexed keywords

2 PROPANOL; ACETONITRILE; UBIDECARENONE;

ACCURACY; ARTICLE; DRUG IMPURITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MASS SPECTROMETRY; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SYNTHESIS;

EID: 79961149486     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Palamakula, A., and Khan, M.A. Int. J. Pharm, 2004, 273, 63-73.
2. Kang, B.K., Lee, J.S., Chon, S.K, Jeong, S.Y, Yuk, S.H, Khang, G., Lee, H.B., and Cho, S.H. Int. J. Pharm, 2004, 274, 65-73.
3. Turunen, M., Olsson, J., and Dallner, G. Biochim. Biophys. Acta, 2004, 1660, 171-199.
4. Tarnopolsky, M.A., and Beal, M.F., Ann. Neurol, 2001,49, 561-574.
5. Hermann, D.D., Am. J. Cardiovasc. Drugs, 2002, 2, 173-196.
6. Gaby, A.R., Altern. Med. Rev, 1996, 1, 168-175.
7. Roffe, L., Schmidt, K., and Ernst, E., J. Clin. Oncol, 2004,22, 4418-4424.
8. Jones, K., Hughes, K., Mischley, L., and McKenna, D.J., Altern. Ther. Health Med, 2004,10, 22-31.
9. Bhagavan, H.N., and Chopra, R.K., Clin. Nutr,2005, 24, 331-338.
10. Beal, M.F., Free Radic. Res, 2002, 36, 455-460.
11. Sharma, S., Kheradpezhou, M., Shavali, S., Refaey, H.E., Eken, J., Hagen, C., and Ebadi, M., Methods Enzymol, 2004, 382, 488-509.
12. Muller, T., Buttner, T., Gholipour, A.F., and Kuhn, W., Neurosci. Lett,2003, 341, 201-204.
13. Lieberman, A., Lyons, K., Levine, J., and Myerburg, R., Parkinsonism Relat. Disord, 2005, 11, 81-84.
14. Folkers, K., and Wolaniuk, A., Drugs Exp. Clin. Res, 1985,11, 539-545.
15. Guzman, D.D., Chem. Market Rep, 2005, 268, 29-30.
16. Buettner, C, Phillips, R.S., Davis, R.B., Gardiner, P., and Mittleman, M.A., Am. J. Cardiol, 2007, 99, 661-666.
17. Karpínska, J., Mikołúc, B., Piotrowska-JastrzsubL/subebska, J., J. Pharm. Biomed. Anal, 1998, 17, 1345-1350.
18. Bunaciu, A.A., Aboul-Enein, H.Y., and Fleschin, S., Prep.Biochem. Biotechnol, 2007, 37, 59-65.
19. Karpínska, J., Mikołúc, B., Motkowski, R., and Piotrowska-JastrzsubL/subebska, J., J. Pharm. Biomed. Anal, 2006, 42, 232-236.
20. Grossi, G., Bargossi, A.M., Fiorella, P.L., and Battino, S.P.M., J. Chromatogr. A, 1992, 593, 217-226.
21. Kommuru, T.R, Khan, M.A., Ashraf, M., Kattenacker, R., and Reddy, I.K., J.Pharm. Biomed. Anal, 1998, 16, 1037-1040.
22. Narasimha Rao, C.V., Prabhu, S.R., Mahendra, K., Kanwal Raj., Srivastava, S., Bhaduri, A.P., "Process for the Purification of Solanesol(95%) from crude/enriched extracts of tobacco green leaf/tobacco Cured leaf/tobacco waste", 2007, Indian Patent No.211204.
23. L ́isa, M., Holc ̌apek, M., R ̌ezanka, T., Kaba ́tova ́, N., J. Chromatogr. A, 2007, 1146, 67-77.
24. Yakushina, L., and Taranova, A., J. Pharm. Biomed. Anal, 1995,13, 715 718.
25. ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland, 2005, Q2A (R1).